Navigation Links
New Treatment Mooted For Blood Pressure

InterCure, Ltd. has announced that it will be publishing a peer-reviewed clinical overview to test how efficient device-guided breathing is. RESPeRATE, a over-the-counter// therapeutic device that is approved by FDA could be a viable option to treat hypertension, the study says.

The article, published in the General Medicine Journal (http://www.medscape.com/viewarticle/539099) of Medscape (NASDAQ:WBMD), is authored by William J. Elliott, MD, PhD, professor of Preventive Medicine, Internal Medicine and Pharmacology at Rush Medical College, Ill., and Joseph L. Izzo, Jr., MD, professor of medicine and vice chair of Medical Research at the University of Buffalo, N.Y.

The article confirms the body of evidence from seven published clinical studies concluding that routine use of RESPeRATE, either alone or as an adjunctive treatment with lifestyle modifications or prescription drugs, significantly lowered blood pressure with no adverse side effects. The study also reviews the physiological mechanism of action of device-guided breathing.

A summary of the results of the seven studies shows an average all-day reduction of 14/8 mm Hg within four to six weeks of commencement of 15-minute-daily treatments with RESPeRATE. The reduction in blood pressure was consistent between studies, whether measurements were taken in the home, 24-hour ambulatory setting or physician's office. Larger blood pressure reductions were seen in older individuals and those with higher baseline readings, regardless of whether they were also being treated with prescription antihypertensive medications.

The authors summarize the patient populations for whom device-guided breathing appears to be beneficial: (1) prehypertensives and white-coat or labile hypertensives who might benefit from reducing stress and sympathetic activity; (2) patients with isolated systolic hypertension; and (3) patients with resistant hypertension (uncontrolled blood pressure despite use of a diuretic and at least two other medications at maximum approved doses).

"When I was first introduced to RESPeRATE, I was skeptical, but after seven trials, the body of data speaks for itself. I have seen first-hand that as long as patients use the device regularly, blood pressure is reduced, with no side effects," says Dr. William Elliott, Rush Medical Center. "Controlling hypertension requires a comprehensive approach, and device-guided breathing provides an additional effective therapeutic modality to offer our patients."

More than 65 million Americans have high blood pressure, and even with traditional treatment methods of diet, exercise and medication, 70 percent of that population is either unable to reach their lower blood pressure goals or can't tolerate the side effects of medications. Left untreated, high blood pressure may lead to heart attack, stroke and kidney or heart failure.

Source: Eurekalert
'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/1/2017)... ... March 01, 2017 , ... Award-winning medical group Allied Anesthesia today announced that, ... underdeveloped nations, averaging more than one trip per year since 1998. Char was named ... features the details of his charitable work. Char has been an Allied Anesthesiologist ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... increase colorectal cancer screening rates by supporting the 80% by 2018 initiative, led ... (CDC) and the National Colorectal Cancer Roundtable (an organization co-founded by ACS and ...
(Date:3/1/2017)... Greenwich, CT (PRWEB) , ... March 01, 2017 , ... ... in the winter months when people don’t want to stop training to brave the ... and setting the treadmill to a small incline can help protect these vulnerable joints, ...
(Date:3/1/2017)... ... ... is Comfort for the Soul”: a loving account of a very special dog, the ... soul-healing comfort provided by God’s presence in the face of deep sorrow. “There is ... dog-loving medical professional whose work takes her to remote areas in the American Northwest, ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... in the lives of those who hear His voice. “Cleansing Thoughts; Glimpses from ... Christian bookstore proprietor who enjoys boating, gardening and crocheting baby items to donate ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... -- The Board of Directors of J M Smith Corporation ... new CEO and Chairman of the Board, effective March ... CEO William R. Cobb .  Turfe was selected ... a wealth of experience in the life sciences, medical ... a pool of incredibly qualified candidates, Alan demonstrated the ...
(Date:3/1/2017)... 1, 2017 Lo stesso sistema sara, visibile nello stand ... Paramed Medical Systems sta installando la settima unità MROpen in Gran ... nuovo centro dell,European Scanning Center (ESC) a Cardiff. ESC attualmente gestisce altri due ... Continue Reading ... ...
(Date:2/28/2017)... Prefilled Syringes Market: Scope and Segmentation ... This report provides a forecast and analysis of ... regional levels. It provides historical data of 2015 ... terms of revenue (US$ Mn) and volume (Bn ... with an outlook on prefilled syringes consumption globally. ...
Breaking Medicine Technology: